2019 American Transplant Congress
Metabolic Liver Transplantation – Can We Afford It?
*Purpose: Despite major improvement in medical and nutritional care of pediatric patients suffering from intoxication inherited metabolic disorders, their long term outcomes remain guarded. Liver…2019 American Transplant Congress
Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant
UC San Francisco, San Francisco, CA
*Purpose: The National Surgical Quality Improvement Program (NSQIP) has been an effective measure in improving the quality of surgical care, while also providing data to…2019 American Transplant Congress
Immunologic Impact Of Native Kidney Function On Liver Transplant Patients
Univ. of Texas Medical Branch, Galveston, TX
*Purpose: Renal failure in the setting of liver transplantation (LTx) is common and has an adverse impact on short and long-term graft and patient survival.…2019 American Transplant Congress
Organ-Specific Injury and Recovery Mechanisms in Post-Transplant Ischemia Reperfusion Injury
*Purpose: Ischemia reperfusion (I/R) injury is a major contributor to short-term graft function. Dissecting organ specific and common molecular pathways associated with I/R injury among…2019 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience
Stanford University Medical Center, Palo Alto, CA
*Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…2019 American Transplant Congress
Use of Low Dose Interleukin-2 to Expand Regulatory T-cells and Facilitate the Complete Discontinuation of Immunosuppression in Human Liver Transplantation
*Purpose: Low dose interleukin-2 (LDIL-2) is capable of expanding endogenous CD4+CD25+FoxP3+ regulatory T-cells (Tregs) in vivo but its role in human solid organ transplantation is…2019 American Transplant Congress
The Risk of Systematic Error in Liver Transplant Opioid Research
Medical University of South Carolina, Charleston, SC
*Purpose: Opioid use before and after liver transplant is strongly associated with morbidity and mortality; yet data assessing opioid utilization has centered on sources with…2019 American Transplant Congress
Factors Associated with Cardiovascular Subclinical Target Organ Damage in Liver Transplant Recipients
*Purpose: Liver transplantation (LT) patients are prone to cardiovascular (CV) morbidity, since LT-related factors can add to the burden of classical risk factors. The aim…2019 American Transplant Congress
Recipients with Model for End-Stage Liver Disease Sodium Score Driven by Renal Dysfunction Have Increased Post-Transplant Mortality
Gastroenterology, University of Pennsylvania, Philadelphia, PA
*Purpose: Since the adoption of the Model for End-stage Liver Disease (MELD) score as a primary means of waitlist prioritization for liver transplantation (LT), an…2019 American Transplant Congress
Whole-Exome Sequencing Identifies PMS1 and DYRK1A Genes Contributing to Occurrence of Liver Cancer
Tongji hospital, Huazhong university, Organ Transplantation, Wuhan, China
*Purpose: Liver cancer is one of the most frequent cancers in China and the accurate landscape of liver cancer, especially of HBV-infected liver cancer in…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 180
- Next Page »